ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements with these filters
Insecticides (India) Ltd will hold a board meeting on November 5, 2026, to approve its Q2 financial results. The trading window remains closed from October 1 until the results declaration.
Q1FY27 was impacted by delayed monsoons, shifting demand later. Despite revenue decline, gross margins improved due to premiumization and inventory management, though EBITDA softened on negative operating leverage.
IIL reported FY26 turnover of ₹2,140 Cr, focusing on premiumization via its 'Tractor Brand'. Strategy emphasizes innovative product launches and international collaborations to shift towards high-margin B2C segments.
Insecticides (India) Ltd reported revenue from operations of ₹611.5 Cr (-11.5% YoY) and net profit of ₹43.9 Cr (-24.4% YoY) for Q1 FY27.
IIL delivered FY26 revenue of ₹2,140cr (up 7%) with EBITDA of ₹227cr. Strategy focuses on premiumization via the Kaeros brand and R&D partnerships with Nissan and Corteva.
Insecticides India delivered steady 7% revenue growth in FY26, balancing raw material inflation through premiumization and strategic partnerships while preparing for a major brand expansion via its new subsidiary, Kairos.
Insecticides (India) reported FY26 turnover of ₹2,140 Cr. Company shifting toward premiumization with B2C premium product share rising from 51% (FY23) to 58% (FY26).
Insecticides (India) Ltd reported revenue from operations of ₹426.3 Cr (+18.8% YoY) and net profit of ₹11.7 Cr (-15.8% YoY) for Q4 FY26.